![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1797835
¼¼°èÀÇ ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)Single-use Duodenoscope Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
¼¼°èÀÇ ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀåÀº 2024³â 1¾ï 5,820¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç CAGR 28.4%·Î ¼ºÀåÇØ, 2034³â±îÁö 20¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ´Â °ÍÀº °¨¿° Á¦¾î¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Àåºñ ¼³°èÀÇ ±â¼úÀû °³¼±, À§Àå ÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÔ´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü´Â ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀÌ°í ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ¿¡ ÁÖ¸ñÇÕ´Ï´Ù.
÷´Ü ³»½Ã°æ ¼Ö·ç¼ÇÀ» äÅÃÇÏ´Â º´¿ø ¹× Ŭ¸®´ÐÀÌ ´Ã¾î³²¿¡ µû¶ó ÀÌ·¯ÇÑ Àåºñ´Â ƯÈ÷ º¹ÀâÇÑ ¸ê±Õ ÀýÂ÷¸¦ ÇÊ¿ä·Î ÇÏÁö ¾ÊÀ¸¸ç °¨¿° À§ÇèÀ» ÁÙÀÌ´Â ÀÏȸ¿ë Çü½ÄÀ» °í·ÁÇÏ¿© ´õ ÀÚÁÖ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. À̹ÌÁö ȣȯ¼º Çâ»ó, ´õ ³ªÀº ¼ÒÀç ¼±ÅÃ, ȯÀÚ Á᫐ ¼³°èµµ ÀÌ·¯ÇÑ ÀÏȸ¿ë µµ±¸ÀÇ Ã¤ÅÃÀ» °¡¼ÓÈÇÕ´Ï´Ù. °Ç° °ü¸® ºÎ¼°¡ ¿ø³» °¨¿°À» ÁÙÀÌ´Â µ¥ Á¡Á¡ ´õ ¸¹Àº ³ë·ÂÀ» ±â¿ïÀÌ¸é¼ ÀÏȸ¿ë ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀÌ ÃÖ¿ì¼± °úÁ¦°¡ µÇ¾ú½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 1¾ï 5,820¸¸ ´Þ·¯ |
¿¹Ãø ±Ý¾× | 20¾ï ´Þ·¯ |
CAGR | 28.4% |
ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇÏ´Â °ÍÀº Áø´Ü Á¤È®µµ¿Í ÀÓ»ó °á°ú¸¦ Çâ»ó½ÃŰ´Â Áö¼ÓÀûÀÎ Á¦Ç° Çõ½ÅÀÔ´Ï´Ù. ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æÀº ½ÊÀÌÁöÀå ³»½Ã°æ Ä¡·á¸¦ À§ÇØ Æ¯º°È÷ ¼³°èµÇ¾úÀ¸¸ç Àç»ç¿ë °¡´ÉÇÑ ¸ðµ¨À» ´ëüÇÏ´Â ¾ÈÀüÇÑ ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÇÑ ¹ø »ç¿ëÇÑ ±â±â´Â Æó±âµÇ¹Ç·Î Àçó¸®¿Í °ü·ÃµÈ ¹®Á¦´Â ¾ø½À´Ï´Ù. ÃÖ±ÙÀÇ ¼³°è °³¼±À¸·Î ±âÁ¸ÀÇ À̹ÌÁö ó¸® Ç÷§Æû°úÀÇ ÅëÇÕÀÌ ¿ëÀÌÇØÁ³À¸¸ç, ó¸® Áß¿¡ ¼±¸íÇÏ°í ½Ç½Ã°£ À̹ÌÁö¸¦ ¾òÀ» ¼ö ÀÖ¾î º¸´Ù Á¤È®ÇÑ Áø´ÜÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÇ·á Àü¹®°¡´Â Ä¡·áÀÇ º¹À⼺À» ÁÙÀ̰í Àç»ç¿ë °¡´ÉÇÑ ¹üÀ§ÀÇ Àçó¸®¿Í °ü·ÃµÈ ¿À¿° À§ÇèÀ» Á¦°ÅÇϱâ À§ÇØ ÀÏȸ¿ë ¸ðµ¨À» ¼±È£ÇÕ´Ï´Ù. º¸´Ù ³ôÀº ½Å·Ú¼º°ú »ç¿ë ÆíÀǼºÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Àåºñ´Â ³»½Ã°æ Ä¡·á¿¡ ÇʼöÀûÀÔ´Ï´Ù.
ºñµð¿À ½ÊÀÌÁöÀå ³»½Ã°æ ¹üÀ§ ºÐ¾ß´Â 2024³â¿¡ Å« ¼öÀÍÀ» ¿Ã·È½À´Ï´Ù. ºñµð¿À ½ÊÀÌÁöÀå ³»½Ã°æÀº ü³» À̹Ì¡ ½Ã½ºÅÛ°ú °áÇÕÇÏ¿© °íÇØ»óµµ À̹ÌÁö¸¦ Á¦°øÇÒ ¼ö Àֱ⠶§¹®¿¡ ³Î¸® ¹Þ¾Æµé¿©Áö°í ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¿µ»ó ó¸® ±â´ÉÀ» ÅëÇØ ÀÓ»óÀÇ´Â ¼ÒȰüÀÇ ÀÛÀº ÀÌ»óÀ» ¼±¸íÇÏ°Ô Ã£À» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñµð¿À ½ºÄÚÇÁ´Â Áø´Ü Á¤¹Ðµµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, ±âÁ¸ ¿À¿°ÀÇ À§ÇèÀÌ ÀÖ´ø ¼¼Á¤À̳ª ¼Òµ¶ÀÇ °øÁ¤À» »ý·«ÇÔÀ¸·Î½á °¨¿°ÀÇ °¡´É¼ºÀ» Àú°¨½Ãŵ´Ï´Ù. °Ç° °ü¸® ½Ã½ºÅÛÀÌ HD ¹× UHD Æ÷¸ËÀ» Æ÷ÇÔÇÑ °í±Þ ºñµð¿À ±â¼úÀ» äÅÃÇÔ¿¡ µû¶ó, ÀÏȸ¿ë ºñµð¿À ½ÊÀÌÁöÀå ³»½Ã°æ¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í ³ô¾ÆÁú °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹«±ÕÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü µµ±¸¸¦ Á¦°øÇÒ ¼ö ÀÖÀ¸¹Ç·Î ¾ÈÀüÇÑ ³»½Ã°æ Ä¡·á¿¡ ÇʼöÀûÀÔ´Ï´Ù.
Á÷Á¢ ÆÇ¸Å ºÎ¹®Àº 2024³â¿¡ 1¾ï 2,240¸¸ ´Þ·¯ÀÇ ±â¿©¸¦ ¹Þ¾ÒÀ¸¸ç, 2034³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 29%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á÷Á¢ ÆÇ¸Å ä³ÎÀº Á¦Á¶¾÷ü°¡ ÀÇ·á Àü¹®°¡¿Í ±ä¹ÐÇÑ °ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖ°Ô ÇÏ°í ¸ÂÃãÇü Áö¿ø, ½Ç½Ã°£ Çǵå¹é ¹× ¸ÂÃãÇü ±³À°À» Á¦°øÇÕ´Ï´Ù. ÀÌ Çù·ÂÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ÃÖÁ¾ »ç¿ëÀÚ ¿ä±¸ »çÇ×À» ´õ Àß ÀÌÇØÇÏ°í ±â¼ú Áö¿ø ¹× Á¦Ç° °³¼±À» °¡¼ÓÈÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÊÀÌÁöÀå ³»½Ã°æ°ú °°Àº ÀÇ·á±â±â¸¦ »ç¿ëÇϸé Á÷Á¢ Âü¿©ÇÔÀ¸·Î½á °í°´ ¼ºñ½ºÀÇ Á¤È®¼ºÀ» º¸ÀåÇÏ°í ºê·£µå Ãæ¼ºµµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¾÷Àº ÀÓ»ó Çǵå¹éÀ» Áï½Ã ¹Þ°í, Á¦Ç° Àü·«À» ÀûÀÀ½Ã۰í, ½ÃÀåÀÇ ¿ä±¸¿¡ µû¶ó ¹Ì·¡ÀÇ Á¦Ç° ¼³°è¸¦ ÃÖÀûÈÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹Ì±¹ ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀåÀº 2024³â 9,410¸¸ ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 29.2%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾çÈ£ÇÑ »óȯ µ¿Çâ°ú °¨¿° À§ÇèÀÇ ÃÖ¼ÒÈ¿¡ ÁßÁ¡À» µÎ°Ô µÇ¾î ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü´Â Àç»ç¿ë °¡´ÉÇÑ ¿É¼Ç¿¡¼ °¨¿° ÅëÁ¦ ³ë·ÂÀ» Áö¿øÇÏ´Â ÀÏȸ¿ë ´ëü¹°·Î À̵¿ÇÕ´Ï´Ù. ´ã°ü Æó»ö, ÃéÀå¿°, ¼Òȱ⠾ÏÀ» Æ÷ÇÔÇÑ ¼Òȱâ ÁúȯÀÇ ºÎ´ã Áõ°¡´Â ¾ÈÀüÇϰí È¿°úÀûÀÎ Áø´Ü µµ±¸¿¡ ´ëÇÑ °ÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº Á¤Ã¥Áö¿ø°ú Àåºñ±â¼úÀÇ Áøº¸µµ ÇÔ²² ½ÃÀå ÀüüÀÇ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¼¼°è ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀåÀ» ¼±µµÇÏ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â PENTAX MEDICAL, FUJIFILM, Boston Scientific, Ambu, STORZ, OLYMPUS, AOHUA µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº ¼ºÀå ½ÃÀå¿¡¼ÀÇ ÀÔÁö¸¦ °ÈÇϱâ À§ÇØ Àü·«Àû ¿òÁ÷ÀÓÀ» Àû±ØÀûÀ¸·Î ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº Áö¼ÓÀûÀÎ Á¦Ç° ¾÷±×·¹À̵å, °íÇØ»óµµ ºñµð¿À ±â¼úÀÇ ÅëÇÕ, ÀÎü°øÇп¡ ±Ù°ÅÇÑ »ç¿ëÀÌ Æí¸®ÇÑ ¸ðµ¨ Ãâ½Ã µî¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ´ëºÎºÐÀº Á÷Á¢ ÆÇ¸Å ºÎ´ë¸¦ È®´ëÇÏ¿© °í°´ ´ëÀÀ°ú ÆÇ¸Å ÈÄ ¼ºñ½º¸¦ °ÈÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ °øµ¿ ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ³ë·Â°ú ÀÇ·á½Ã¼³°úÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀº ÀÌ·¯ÇÑ ±â¾÷µéÀÌ ±â¼úÀû ¿ä±¸¿Í ÀÓ»ó ¿ä±¸¸¦ ¼±Á¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. Á¦Á¶ °øÁ¤ÀÇ ÇÕ¸®È, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ È®º¸, »ý»ê ´É·ÂÀÇ È®´ë´Â ½ÃÀå Á¡À¯À²À» È®´ëÇϱâ À§ÇÑ Àü·«À» Çü¼ºÇϰí ÀÖ½À´Ï´Ù.
The Global Single-Use Duodenoscope Market was valued at USD 158.2 million in 2024 and is estimated to grow at a CAGR of 28.4% to reach USD 2 billion by 2034. The growth is driven by the rising demand for infection control, technological improvements in device design, and the increasing prevalence of gastrointestinal conditions. Healthcare providers are turning to disposable duodenoscopes to improve patient safety and reduce the risk of cross-contamination, a concern that continues to gain traction across clinical settings.
As more hospitals and clinics adopt advanced endoscopic solutions, these devices are being used more frequently, especially in light of their one-time use format, which eliminates the need for complex sterilization procedures and reduces infection risks. Improvements in imaging compatibility, better material choices, and patient-centric designs are also accelerating the adoption of these disposable tools. With the healthcare sector increasingly focused on reducing hospital-acquired infections, the transition to single-use solutions is becoming a top priority.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $158.2 Million |
Forecast Value | $2 Billion |
CAGR | 28.4% |
The market's growth is further supported by continuous product innovation to improve diagnostic accuracy and clinical outcomes. Single-use duodenoscopes are specifically engineered for endoscopic procedures in the duodenum, offering a safer alternative to reusable models. Once used, these devices are discarded, eliminating any reprocessing-related issues. Recent enhancements in design have enabled easier integration with existing imaging platforms, delivering sharper, real-time visuals during procedures and resulting in more precise diagnoses. Healthcare professionals prefer disposable models as they reduce procedural complexity and eliminate contamination risks associated with reprocessing reusable scopes. Greater reliability and ease of use make these devices an integral part of endoscopic procedures.
The video duodenoscope segment generated substantial revenue in 2024. These scopes have gained wide acceptance because they deliver high-definition visuals when paired with in-house imaging systems. Their real-time imaging capabilities allow clinicians to spot even minor anomalies in the gastrointestinal tract with enhanced clarity. In addition to improving diagnostic accuracy, these video scopes reduce the likelihood of infection by eliminating the cleaning and disinfection process, which has historically posed contamination risks. As healthcare systems adopt advanced video technologies, including HD and UHD formats, the demand for disposable video duodenoscopes is projected to rise further. Their ability to provide a sterile, reliable diagnostic tool makes them essential for safe endoscopic procedures.
The direct sales segment contributed USD 122.4 million in 2024 and is anticipated to grow at a CAGR of 29% through 2034. The direct sales channel enables manufacturers to build closer relationships with healthcare professionals, offering tailored support, real-time feedback, and customized training. This collaborative approach ensures a better understanding of end-user requirements and accelerates the delivery of technical support and product improvements. For medical devices like duodenoscopes, direct engagement ensures precision in customer service and strengthens brand loyalty. It also allows companies to receive immediate clinical feedback, adapt product strategies, and optimize future product designs based on market needs.
United States Single-Use Duodenoscope Market reached USD 94.1 million in 2024 and is projected to grow at a CAGR of 29.2% between 2025 and 2034. The demand is rising due to favorable reimbursement trends and a growing emphasis on minimizing infection risks. Healthcare providers in the region are shifting away from reusable options toward disposable alternatives that support infection control efforts. The increasing burden of gastrointestinal diseases, including bile duct blockages, pancreatitis, and GI cancers, is creating a strong demand for safe and effective diagnostic tools. Coupled with policy support and advancements in device technology, the U.S. continues to contribute to overall market expansion.
Prominent companies leading the Global Single-Use Duodenoscope Market include PENTAX MEDICAL, FUJIFILM, Boston Scientific, Ambu, STORZ, OLYMPUS, and AOHUA. These companies are actively pursuing strategic moves to strengthen their position in the growing market. They focus on continuous product upgrades, integrating high-definition video technologies, and launching models with improved ergonomics and ease of use. Many are expanding their direct sales force to enhance customer engagement and post-sale service. In addition, collaborative R&D efforts and strategic partnerships with healthcare facilities help these players stay ahead of technological demands and clinical needs. Streamlining manufacturing processes, securing regulatory approvals, and scaling production capabilities form their strategy to capture greater market share.